Pyxis Oncology
Stock Forecast, Prediction & Price Target
Pyxis Oncology Financial Estimates
Pyxis Oncology Revenue Estimates
Pyxis Oncology EBITDA Estimates
Pyxis Oncology Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $400K Low: $399.33K High: $400.44K avg. 0% | Avg: $6.25M Low: $6.23M High: $6.25M avg. 1462.5% | Avg: $18.57M Low: $18.54M High: $18.59M avg. 197.26% | Avg: $46.67M Low: $46.60M High: $46.73M avg. 151.24% |
Net Income
% change YoY
| $-81.53M N/A | $-117.95M -44.66% | $-73.79M 37.44% | Avg: $-87.27M Low: $-59.45M High: $-55.06M avg. -18.26% | Avg: $-113.51M Low: $-55.06M High: $-50.67M avg. -30.06% | Avg: $-68.10M Low: $-68.20M High: $-67.95M avg. 40.00% | Avg: $-81.80M Low: $-81.92M High: $-81.62M avg. -20.11% |
EBITDA
% change YoY
| $-63.48M N/A | $-123.48M -94.50% | $-78.49M 36.43% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$2.53 N/A | -$3.57 -41.10% | -$1.85 48.17% | Avg: -$1.43 Low: -$1.49 High: -$1.38 avg. 22.52% | Avg: -$1.33 Low: -$1.38 High: -$1.27 avg. 7.55% | Avg: -$1.71 Low: -$1.71 High: -$1.7 avg. -28.80% | Avg: -$2.05 Low: -$2.05 High: -$2.05 avg. -20.11% |
Operating Expenses
% change YoY
| $69.71M N/A | $123.48M 77.11% | $82.19M -33.43% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Pyxis Oncology stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -7.11% in 2025-2028.
We have gathered data from 4 analysts. Their low estimate is -59.45M, average is -87.27M and high is -55.06M.
What is Pyxis Oncology stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 452.75% in 2025-2028.
We have gathered data from 3 analysts. Their low revenue estimate is $399.33K, average is $400K and high is $400.44K.
What is Pyxis Oncology stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -4.71% in 2025-2028.
We have gathered data from 4 analysts. Their low earnings per share estimate is -$1.49, average is -$1.43 and high is $-1.38.
What is the best performing analyst?
In the last twelve months analysts have been covering Pyxis Oncology stock. The most successful analyst is Farzin Haque.